525 related articles for article (PubMed ID: 1377599)
1. 1-beta-D-arabinofuranosylcytosine-diphosphate-choline is formed by the reversal of cholinephosphotransferase and not via cytidylyltransferase.
Kucera GL; Capizzi RL
Cancer Res; 1992 Jul; 52(14):3886-91. PubMed ID: 1377599
[TBL] [Abstract][Full Text] [Related]
2. Formation of 1-beta-D-arabinofuranosylcytosine diphosphate choline in cultured human leukemic RPMI 6410 cells.
Lauzon GJ; Paran JH; Paterson AR
Cancer Res; 1978 Jun; 38(6):1723-9. PubMed ID: 274174
[TBL] [Abstract][Full Text] [Related]
3. Formation of 1-beta-D-arabinofuranosylcytosine diphosphate choline in neoplastic and normal cells.
Lauzon GJ; Paterson AR; Belch AW
Cancer Res; 1978 Jun; 38(6):1730-3. PubMed ID: 274175
[TBL] [Abstract][Full Text] [Related]
4. Regulation of phospholipid biosynthesis in Saccharomyces cerevisiae by CTP.
McDonough VM; Buxeda RJ; Bruno ME; Ozier-Kalogeropoulos O; Adeline MT; McMaster CR; Bell RM; Carman GM
J Biol Chem; 1995 Aug; 270(32):18774-80. PubMed ID: 7642527
[TBL] [Abstract][Full Text] [Related]
5. Cytidine-5'-diphosphocholine affects CTP-phosphocholine cytidylyltransferase and lyso-phosphatidylcholine after transient brain ischemia.
Adibhatla RM; Hatcher JF; Dempsey RJ
J Neurosci Res; 2004 May; 76(3):390-6. PubMed ID: 15079868
[TBL] [Abstract][Full Text] [Related]
6. The enhancement of phosphatidylcholine biosynthesis by angiotensin II in H9c2 cells.
Tran K; Man RY; Choy PC
Biochim Biophys Acta; 1995 Dec; 1259(3):283-90. PubMed ID: 8541336
[TBL] [Abstract][Full Text] [Related]
7. Formulation, stability, and antitumor activity of 1-beta-D-arabinofuranosylcytosine conjugate of thioether phospholipid.
Hong CI; Bernacki RJ; Hui SW; Rustum Y; West CR
Cancer Res; 1990 Jul; 50(14):4401-6. PubMed ID: 2364392
[TBL] [Abstract][Full Text] [Related]
8. Saturation of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate accumulation in leukemia cells during high-dose 1-beta-D-arabinofuranosylcytosine therapy.
Plunkett W; Liliemark JO; Adams TM; Nowak B; Estey E; Kantarjian H; Keating MJ
Cancer Res; 1987 Jun; 47(11):3005-11. PubMed ID: 3471322
[TBL] [Abstract][Full Text] [Related]
9. Incorporation of fludarabine and 1-beta-D-arabinofuranosylcytosine 5'-triphosphates by DNA polymerase alpha: affinity, interaction, and consequences.
Gandhi V; Huang P; Chapman AJ; Chen F; Plunkett W
Clin Cancer Res; 1997 Aug; 3(8):1347-55. PubMed ID: 9815818
[TBL] [Abstract][Full Text] [Related]
10. Intracellular processes associated with vesicular transport from endoplasmic reticulum to Golgi and exocytosis: ethanol-induced changes in membrane biogenesis.
Slomiany A; Grabska M; Piotrowski E; Sengupta S; Morita M; Kasinathan C; Slomiany BL
Arch Biochem Biophys; 1994 Apr; 310(1):247-55. PubMed ID: 8161212
[TBL] [Abstract][Full Text] [Related]
11. Regulation of the cytidine phospholipid pathways in human cancer cells and effects of 1-beta-D-arabinofuranosylcytosine: a noninvasive 31P nuclear magnetic resonance study.
Daly PF; Zugmaier G; Sandler D; Carpen M; Myers CE; Cohen JS
Cancer Res; 1990 Feb; 50(3):552-7. PubMed ID: 2153442
[TBL] [Abstract][Full Text] [Related]
12. 1-beta-D-arabinofuranosylcytosine nucleotide inhibition of sialic acid metabolism in WI-38 cells.
Myers-Robfogel MW; Spataro AC
Cancer Res; 1980 Jun; 40(6):1940-3. PubMed ID: 7371029
[TBL] [Abstract][Full Text] [Related]
13. Phosphatidylcholine biosynthesis via the CDP-choline pathway in Saccharomyces cerevisiae. Multiple mechanisms of regulation.
McMaster CR; Bell RM
J Biol Chem; 1994 May; 269(20):14776-83. PubMed ID: 8182083
[TBL] [Abstract][Full Text] [Related]
14. Minimum dose of fludarabine for the maximal modulation of 1-beta-D-arabinofuranosylcytosine triphosphate in human leukemia blasts during therapy.
Gandhi V; Estey E; Du M; Keating MJ; Plunkett W
Clin Cancer Res; 1997 Sep; 3(9):1539-45. PubMed ID: 9815841
[TBL] [Abstract][Full Text] [Related]
15. Characterization of cytidylyltransferase enzyme activity through high performance liquid chromatography.
Brault JP; Friesen JA
Anal Biochem; 2016 Oct; 510():26-32. PubMed ID: 27443959
[TBL] [Abstract][Full Text] [Related]
16. Modulation of the metabolism and pharmacokinetics of 1-beta-D-arabinofuranosylcytosine by 1-beta-D-arabinofuranosyluracil in leukemic mice.
Chandrasekaran B; Capizzi RL; Kute TE; Morgan T; Dimling J
Cancer Res; 1989 Jun; 49(12):3259-66. PubMed ID: 2720678
[TBL] [Abstract][Full Text] [Related]
17. CDP-choline: 1,2-diacylglycerol cholinephosphotransferase from rat liver microsomes. II. Photoaffinity labeling by radioactive CDP-choline analogs.
Ishidate K; Matsuo R; Nakazawa Y
Biochim Biophys Acta; 1992 Feb; 1124(1):36-44. PubMed ID: 1311951
[TBL] [Abstract][Full Text] [Related]
18. Relationship of 1-beta-D-arabinofuranosylcytosine in plasma to 1-beta-D-arabinofuranosylcytosine 5'-triphosphate levels in leukemic cells during treatment with high-dose 1-beta-D-arabinofuranosylcytosine.
Liliemark JO; Plunkett W; Dixon DO
Cancer Res; 1985 Nov; 45(11 Pt 2):5952-7. PubMed ID: 4053067
[TBL] [Abstract][Full Text] [Related]
19. Modulation of arabinosylnucleoside metabolism by arabinosylnucleotides in human leukemia cells.
Gandhi V; Plunkett W
Cancer Res; 1988 Jan; 48(2):329-34. PubMed ID: 3335008
[TBL] [Abstract][Full Text] [Related]
20. Regulation of phosphatidylcholine biosynthesis in activated alveolar type II cells.
Miller BE; HooK GE
Am J Respir Cell Mol Biol; 1989 Aug; 1(2):127-36. PubMed ID: 2559761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
